Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses
Functions of miRNAs in controlling NK cell lineage commitment.
»
12/02/25
Multi-omic profiling provides insights into the heterogeneity, microenvironmental features, and biomarker landscape of small-cell lung cancer
High heterogeneity across/within neuroendocrine and non-neuroendocrine subtypes.
»
12/02/25
A novel role of secreted methionine adenosyltransferase α2 in colorectal liver metastases
RKO cells treated with MATα2-t activated focal adhesion kinase.
»
12/02/25
Machine learning-based integration of dosiomics and pre-radiotherapy multimodal MRI radiomics for survival stratification in patients with glioblastoma multiforme
Dosiomic and pre-radiotherapy MRI-derived radiomic features capable of stratifying GBM patients.
»
12/02/25
Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma
Sarcopenia and myosteatosis significant independent prognostic factors.
»
12/03/25
Novel cyclic C5-curcuminoids possess anticancer activities against HeLa cervix carcinoma, HEC-1A adenocarcinoma, and T24 bladder carcinoma cells
Compound 4 as possible synthetic cyclic C5-curcuminoid.
»
12/03/25
CircRNF10 sequestrates β-catenin by a dual regulatory circuit of direct degradation and a miR-1275/DKK3-mediated inhibition in driver gene- negative lung adenocarcinoma
CircRNF10 promotes β-catenin degradation through direct interaction and modulation of miR-1275/DKK3 signaling.
»
12/05/25
Acute kidney injury predicts mortality, sarcopenia and postoperative morbidity in myxofibrosarcoma patients undergoing surgical resection
AKI occurred in 38.8% of patients.
»
12/05/25
Targeting Musashi-2 to counteract senescence and resistance in chronic myeloid leukemia: enhancing the efficacy of imatinib therapy
MSI2 inhibition moderately induced apoptosis.
»
12/07/25
Validation and clinical evaluation of a comprehensive circulating tumor DNA assay for genomic profiling in solid tumors
CtDNA findings contributed to documented change in therapy.
»
12/08/25
< Prev
Next >